| Active Market | Forge Price1 | Last Funding Round | Trade Eligibility | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Company | Sector & Subsector | Market Activity4   |
Highest Bid | Lowest Ask | Last Matched | +/- to LFR | $ Total Bids |
$ Total Asks |
# Bids |
# Asks |
Current Price |
6-month |
1-year |
Total Funding |
Round | Date | Amount Raised |
Post-Money Valuation3 |
Price |
Key Investors | Common | Preferred | Fund | ||
 | Prolific Machines | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $138.13M | Series B-3 | 9/15/2026 | $50M | $280.98M | $2.77 | Prevail Venture Capital | ||||
 | Sapiom | Fintech Fintech Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $47.94M | Series A-1 | 8/5/2026 | $32.62M | $284.15M | $15.16 | Dragonfly, Accel, Gradient, Coinbase Ventures, Operator Collective, Formus Capital, VanEck Ventures, Okta Ventures, Menlo Ventures, Anthropic, Array Ventures | ||||
 | TriGemX Bio | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $573.45M | Series E | 10/1/2026 | $93.99M | $341.19M | $0.79 | The Column Group, TCGX, Viking Global Investors | ||||
 | Vedanta Biosciences | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $126.86M | Series B-1 | 8/6/2026 | $22.57M | $113.87M | $0.17 | AMR Action Fund, BNP Paribas | ||||
 | WindBorne Systems | Enterprise Software Business Operations | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $61.18M | Series B | 8/5/2026 | $37.12M | $221.91M | $7.07 | Khosla Ventures, Galvanize, Translink Capital, Lux Capital | ||||
 | Wunderkind | Enterprise Software Sales & Marketing / Adtech | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $217M | Series D-SC | 8/4/2026 | $75.48M | $422.37M | $5.09 | Archer Capital Group | ||||
 | Abcuro | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $353.25M | Series D-1 | 8/18/2026 | $32.35M | $120.99M | $0.60 | New Leaf Venture Partners, Rock Springs Capital, Abrdn, Bain Capital Life Sciences, Samsara BioCapital, Redmile Group, Mass General Brigham Ventures, RA Capital Management, Pontifax, Sanofi Ventures, Foresite Capital, New Enterprise Associates, Eurofarma Ventures, Kaitai Capital, Soleus Capital, Nancy Chang, ShangBay Capital | ||||
 | Cardinal Data Power | Energy Other Energy | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $70M | Series A-1 | 7/23/2026 | $54.05M | $318.74M | $1.44 | Hood River Capital Management, Empery Digital | ||||
 | Circle Pharma | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $303.25M | Series E-1 | 9/16/2026 | $62.01M | $245.27M | $0.27 | The Column Group, Nextech Invest, RA Capital Management, Euclidean, Eli Lilly and Company | ||||
 | Daloopa | Fintech Fintech Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $105.91M | Nonvoting Series C | 8/19/2026 | $3M | $326.42M | $6.46 | Undisclosed Investors | ||||
 | Detect | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $77.02M | Series A-1 | 7/29/2026 | $31.99M | $118.22M | $1.22 | Undisclosed Investors | ||||
 | Presto | Consumer & Lifestyle Consumer & Lifestyle Enterprise Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $38.45M | Subordinated | 9/28/2026 | $10M | $108.13M | $1.54 | REMUS Capital | ||||
 | Quadric | Industrial Manufacturing | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $85.75M | Series C-3 | 7/13/2026 | $17.75M | $266.75M | $12.20 | IFC, Pear VC, Uncork Capital, BEENEXT, Offline Ventures | ||||
 | Sidecar Health | Fintech Insurance | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $540.9M | Series E | 8/31/2026 | $149.67M | $463.29M | $10.88 | Undisclosed Investors | ||||
 | Skan AI | Enterprise Software Business Operations | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | $2.18M | -- | 1 | Not available | -- | -- | $116.98M | Series C | 8/12/2026 | $60M | $450.47M | $10.89 | Cathay Innovation, Dell Technologies Capital, Citi Ventures, Bloomberg Beta, State Farm Ventures, Wipro Ventures | ||||
 | Smack Technologies | Enterprise Software Productivity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $93.77M | Series B | 8/18/2026 | $61.45M | $391.57M | $11.12 | Costanoa Ventures, First In, Point72 Ventures, Geodesic Capital, Nomi Capital, Felicis, Scribble Ventures, Fortitude Ventures, Bloomberg, Palumni VC | ||||
 | Stuut | Fintech Fintech Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $103.05M | Series B | 9/3/2026 | $62.5M | $353.67M | $11.59 | Insight Partners, Andreessen Horowitz, M12, Activant Capital | ||||
 | Aquant | Enterprise Software Business Operations | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $148.07M | Series D-1 | 8/4/2026 | $19.96M | $41.63M | $0.43 | Undisclosed Investors | ||||
 | Archy | Healthcare Healthcare Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $96.28M | Series C | 9/11/2026 | $50M | $278.25M | $4.98 | JMI Equity, TCV, Entree Capital, Bessemer Venture Partners, CRV, Alven Capital Partners | ||||
 | BackOps AI | Enterprise Software Productivity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $77.5M | Series B | 9/16/2026 | $42M | $250.66M | $9.55 | Insight Partners, Theory Ventures, Construct Capital, Gradient Ventures, 10VC | ||||
 | Delix Therapeutics | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $188.04M | Series C | 9/28/2026 | $80.18M | $275M | $2.55 | Johnson & Johnson | ||||
 | Finite State | Enterprise Software Cybersecurity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $91.04M | Series C-1 | 7/24/2026 | $12.5M | $121.82M | $1.08 | Undisclosed Investors | ||||
 | MIND | Enterprise Software Data Management / Storage | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $95.32M | Series B | 9/17/2026 | $57.3M | $201.02M | $1.04 | Crosspoint Capital Partners, YL Ventures, Paladin Capital Group | ||||
 | Mundo AI | Enterprise Software Productivity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $24.11M | Series A | 8/25/2026 | $20M | $236.55M | $28.48 | GreatPoint Ventures, Y Combinator, Next Frontier Ventures, E12 Ventures | ||||